INTEGRATED BIOPHARMA INC Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Integrated Biopharma Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • Integrated Biopharma Inc Return On Equity for the quarter ending September 30, 2024 was 2.26 %.
  • Integrated Biopharma Inc annual Return On Equity for 2024 was 0.59 %.
  • Integrated Biopharma Inc annual Return On Equity for 2023 was -0.24 %, a 101% decline from 2022.
  • Integrated Biopharma Inc annual Return On Equity for 2022 was 23.1 %, a 71.5% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 0.59 +0.83 Jul 1, 2023 Jun 30, 2024
2023 -0.24 -23.3 -101% Jul 1, 2022 Jun 30, 2023
2022 23.1 -57.8 -71.5% Jul 1, 2021 Jun 30, 2022
2021 80.9 -24.3 -23.1% Jul 1, 2020 Jun 30, 2021
2020 105 -66 -38.6% Jul 1, 2019 Jun 30, 2020
2019 171 +183 Jul 1, 2018 Jun 30, 2019
2018 -11.4 -13.2 -739% Jul 1, 2017 Jun 30, 2018
2017 1.78 +10.6 Apr 1, 2017 Mar 31, 2018
2016 -8.86 -1.03 -13.2% Apr 1, 2016 Mar 31, 2017
2015 -7.82 -6.51 -494% Jul 1, 2014 Jun 30, 2015
2014 -1.32 -0.46 -53.5% Jul 1, 2013 Jun 30, 2014
2013 -0.86 -32.2 -103% Jul 1, 2012 Jun 30, 2013
2012 31.3 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.